Personalized medicine and disruptive innovation: Implications for technology assessment
Explore this paper's citation graph
Summary
There is a question of whether personalized health care will require a new approach to technology assessment and dissemination, one that embraces the tremendous potential of the vision of personalized medicine.
- Type
- article
- Published
- 2009-07-14
- Cited by
- 28
- References
- 18
- Access
- Open access
- OpenAlex
- https://openalex.org/W1988494345
- Semantic Scholar
- https://api.semanticscholar.org/CorpusID:52873197
Keywords
Personalized medicine, Disruptive technology, Medicine, Precision medicine, Engineering ethics
References
- Pharmacogenetics and the practice of medicine
- Overregulation of Health Care: Musings on Disruptive Innovation Theory
- Substituting diagnostic services. New tests only partly replace older ones.
- Implications of pharmacogenomics for drug development and clinical practice.
- Application of dual-genome oligonucleotidearray-based comparative genomic hybridization to the molecular diagnosis of mitochondrial DNA deletion and depletion syndromes
- A genomic strategy to refine prognosis in early-stage non-small-cell lung cancer.
- High and Rising Health Care Costs. Part 2: Technologic Innovation
- ORGANISATIONAL RESPONSES TO DISCONTINUOUS INNOVATION: A CASE STUDY APPROACH
- A physician's view of managed care.
- The theory of economic development
- Roles of nonphysician clinicians as autonomous providers of patient care.
- Draft Guidance for Industry, Clinical Laboratories, and FDA Staff: In Vitro Diagnostic Multivariate Index Assays
Cited by
- Molecular technology vs clinical practice: a hypothesis in genetics
- Personalized pharmacotherapy in psychiatry.
- Viability Radar: A Practical Tool for Assessing the Viability of Transformative Service Innovations in a Healthcare Context
- Electronic Communities of Care - Measuring the Benefits
- The role of ICT in supporting disruptive innovation: a multi-site qualitative study of nurse practitioners in emergency departments
- Un cadre pour évaluer la valeur des diagnostics en laboratoire
- Assessing multilevel determinants of adoption and implementation of genomic medicine: an organizational mixed-methods approach
- Innovation Spaces: Six Strategies to Inform Health Care
- A Framework for Assessing the Value of Laboratory Diagnostics
- Analysing stratified medicine business models and value systems: innovation-regulation interactions.
- The impact of specialty pharmaceuticals as drivers of health care costs.
- Clinician Acceptance is the Key Factor for Sustainable Telehealth Services
- Systematic review of pharmacoeconomic studies of pharmacogenomic tests.
- Mobile teledermatology for a prompter and more efficient dermatological care in rural Mongolia
- Insurance Coverage Policies for Personalized Medicine
- Health technology assessment in the era of personalized health care
- Mapping the Patent Landscape in the Field of Personalized Medicine
- Disruptive innovation in rural American healthcare: the physician assistant practice
- Emerging health technology firms’ strategies and their impact on economic and healthcare system actors: a qualitative study
- Defining Value in "Value-Based Healthcare" : Report of the Expert Panel on effective ways of investing in Health (EXPH)
Related papers
- The future of precision medicine: towards a more predictive personalized medicine.
- Genomic medicine on the frontier of precision medicine
- Detecting Personalized Determinants During Drug Treatment from Omics Big Data.
- TRANSFORMING HEALTHCARE WITH PRECISION MEDICINE: UNVEILING THE FUTURE OF PERSONALIZED TREATMENT
- Critical Care and Personalized or Precision Medicine: Who needs whom?
- Precision Medicine: Tailoring Treatment to the Individual's Genomic Profile
- Prediction and Recommendation of Precision Medicine for Cancer using Machine Learning Techniques
- Advances in Genomic Data and Biomarkers: Revolutionizing NSCLC Diagnosis and Treatment